JNJ vs PG
Johnson & Johnson vs The Procter & Gamble Company · Updated Jun 26, 2026
JNJ — 16 winsPG — 7 wins
Price Performance
JNJ +61.09%PG -6.39%
Performance
| JNJ | PG | |
|---|---|---|
| 1 Month | +6.57% | +3.74% |
| 3 Months | +2.31% | +3.03% |
| 6 Months | +18.32% | +1.92% |
| YTD | +18.54% | +3.49% |
| 1 Year | +61.19% | -6.77% |
| 3 Year | +40.27% | +4.65% |
| 5 Year | +64.76% | +5.02% |
Yearly Returns
| YTD | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| JNJ | +18.1% | +43.7% | -9.6% | -12.0% | +3.0% | +9.3% | +7.8% | +14.2% | -7.3% | +20.6% | +14.7% | -1.7% |
| PG | +4.7% | -13.7% | +12.7% | -3.3% | -7.0% | +18.7% | +12.8% | +36.8% | +1.4% | +9.1% | +7.3% | -12.2% |
Valuation
| JNJ | PG | |
|---|---|---|
| P/E Ratio | 28.36 | 21.68 |
| Forward P/E | 11.17 | 11.86 |
| PEG Ratio | 2.75 | 4.79 |
| P/S Ratio | 5.78 | 3.97 |
| P/B Ratio | 6.86 | 6.28 |
| EV/EBITDA | 17.48 | 15.29 |
Financials
| JNJ | PG | |
|---|---|---|
| EPS (TTM) | $8.65 | $6.84 |
| Gross Margin | +71.49% | +49.51% |
| Operating Margin | +26.58% | +21.55% |
| Net Margin | +21.76% | +0.09% |
| ROE | +25.92% | +23.23% |
| ROA | +10.47% | +9.90% |
| Debt/Equity | 0.22 | 0.68 |
Growth
| JNJ | PG | |
|---|---|---|
| Revenue Growth YoY | +9.91% | +7.38% |
| Revenue Growth QoQ | -2.04% | -4.38% |
| EPS Growth YoY | -52.86% | +5.84% |
| EPS Growth QoQ | +1.90% | -8.43% |
Technical
| JNJ | PG | |
|---|---|---|
| RSI (14) | 64.19 | 53.32 |
| % From 20-Day SMA | +5.21% | +0.83% |
| % From 50-Day SMA | +6.50% | +1.81% |
| % From 200-Day SMA | +13.07% | -0.32% |
| % From 52-Week High | -2.54% | -11.32% |
| % From 52-Week Low | +62.75% | +7.77% |
Analyst Ratings
JNJ
Buy(24 analysts)
Strong SellHoldStrong Buy
Price Target
$251.55
+9.46% upside
PG
Buy(17 analysts)
Strong SellHoldStrong Buy
Price Target
$159.00
+5.33% upside
Overview
| JNJ | PG | |
|---|---|---|
| Sector | Healthcare | Consumer Defensive |
| Industry | Drug Manufacturers - General | Household & Personal Products |
| Exchange | NYSE | NYSE |
| Market Cap | $556.76B | $343.93B |
| Shares Outstanding | 2.41B | 2.33B |
| Avg Volume (10D) | 9.55M | 9.29M |
| Dividend Yield | 2.27% | 2.88% |
Frequently Asked Questions
Is JNJ or PG a better buy right now?
Based on 23 comparable metrics, JNJ leads in 16 categories while PG leads in 7. JNJ has a consensus analyst rating with 24 analysts covering the stock. Neither stock should be purchased based on a single comparison — consider your investment goals and risk tolerance.
Which stock has better performance, JNJ or PG?
Over the past year, JNJ returned +61.19% compared to PG's -6.77%. In the short term (1 month), JNJ returned +6.57% vs PG's +3.74%.
Is JNJ or PG more expensive?
JNJ trades at a P/E of 28.36 compared to PG's 21.68. On a price-to-sales basis, JNJ trades at 5.78x vs PG's 3.97x. Forward P/E: JNJ at 11.17 vs PG at 11.86.
Which stock has higher growth, JNJ or PG?
JNJ's revenue grew +9.91% year-over-year compared to PG's +7.38%. EPS growth: JNJ at -52.86% vs PG at +5.84%.
Do JNJ and PG pay dividends?
JNJ pays a dividend with a yield of 2.27%. PG pays a dividend with a yield of 2.88%.
Which stock do analysts prefer, JNJ or PG?
JNJ has 24 analysts with a target price of $251.55 (+9.46% upside). PG has 17 analysts with a target of $159.00 (+5.33% upside).
Data updated daily. All comparisons based on latest available market data. Not investment advice.